IMAX Corporation (NYSE:IMAX – Get Free Report) insider Kevin Douglas sold 330,200 shares of the firm’s stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $37.82, for a total value of $12,488,164.00. Following the transaction, the insider owned 3,657,450 shares in the company, valued at $138,324,759. This represents a 8.28% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Kevin Douglas also recently made the following trade(s):
- On Monday, March 16th, Kevin Douglas sold 237,800 shares of IMAX stock. The stock was sold at an average price of $37.82, for a total value of $8,993,596.00.
IMAX Trading Up 2.9%
Shares of NYSE IMAX opened at $39.21 on Tuesday. The stock has a market cap of $2.12 billion, a P/E ratio of 63.24, a P/E/G ratio of 1.80 and a beta of 0.33. IMAX Corporation has a twelve month low of $20.48 and a twelve month high of $43.16. The stock has a 50 day moving average of $37.07 and a two-hundred day moving average of $35.13.
More IMAX News
Here are the key news stories impacting IMAX this week:
- Positive Sentiment: Christopher Nolan’s upcoming film The Odyssey secured extended theatrical windows and confirmed IMAX showings — a potential near‑term box‑office and premium‑ticket catalyst that can lift admissions and theater partner demand for IMAX formats. Christopher Nolan’s The Odyssey secures extended theatrical windows & IMAX showings
- Positive Sentiment: Recent analyst coverage shows an average price target around $43.70, above current levels — signals analyst confidence and provides an upside reference that may support buying interest. IMAX Receives $43.70 Average PT from Analysts
- Neutral Sentiment: Media mentions of specialty screenings (an anime classic in IMAX) highlight continued content diversification and niche programming, which help fill off‑peak dates but are unlikely to move results dramatically on their own. Hollywood Minute: An anime classic in IMAX
- Negative Sentiment: IMAX CEO Richard Gelfond sold roughly $4.9M of stock (exercise + sale) in early March — an insider sale that investors may view cautiously even if it was liquidity from option vesting rather than a vote of no confidence. IMAX CEO Sold Shares Worth $4.9 Million
- Negative Sentiment: Reputational headline: Geoff Keighley publicly criticized the Oscars for omitting late IMAX pioneer David Keighley from the In Memoriam segment — negative PR within the film community that could irk creative partners, though direct financial impact is likely limited. Oscars 2026: IMAX pioneer David Kieghley left out from ‘In Memoriam’ segment
Hedge Funds Weigh In On IMAX
Several institutional investors and hedge funds have recently added to or reduced their stakes in IMAX. JPMorgan Chase & Co. boosted its stake in shares of IMAX by 10.9% in the second quarter. JPMorgan Chase & Co. now owns 1,029,602 shares of the company’s stock valued at $28,788,000 after buying an additional 101,048 shares in the last quarter. Divisadero Street Capital Management LP purchased a new position in shares of IMAX in the 3rd quarter valued at about $20,975,000. Principal Financial Group Inc. lifted its stake in shares of IMAX by 67.8% in the third quarter. Principal Financial Group Inc. now owns 70,927 shares of the company’s stock valued at $2,323,000 after purchasing an additional 28,667 shares during the period. Zhang Financial LLC acquired a new stake in shares of IMAX in the third quarter valued at about $903,000. Finally, Citigroup Inc. boosted its holdings in IMAX by 267.7% during the third quarter. Citigroup Inc. now owns 66,769 shares of the company’s stock worth $2,187,000 after buying an additional 48,609 shares in the last quarter. Institutional investors and hedge funds own 93.51% of the company’s stock.
Analyst Ratings Changes
A number of research analysts have commented on IMAX shares. The Goldman Sachs Group lifted their price objective on shares of IMAX from $37.00 to $41.00 and gave the company a “neutral” rating in a research note on Monday, March 2nd. Wall Street Zen cut IMAX from a “strong-buy” rating to a “buy” rating in a research report on Saturday, February 28th. Macquarie Infrastructure increased their price objective on IMAX from $39.00 to $44.00 and gave the stock an “outperform” rating in a research report on Thursday, January 15th. B. Riley Financial reiterated a “buy” rating on shares of IMAX in a research note on Monday, December 8th. Finally, Barrington Research restated an “outperform” rating and set a $42.00 price target on shares of IMAX in a research note on Monday, January 26th. Ten research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $43.70.
View Our Latest Stock Report on IMAX
About IMAX
IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.
Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.
Featured Articles
- Five stocks we like better than IMAX
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.
